ORXOF (Orexo AB) Shiller PE Ratio: (As of Aug. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORXOF Orexo AB ORXOF
27 GF Score
Price $1.55
GF Value $0.35
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Orexo AB Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Orexo AB  (OTCPK:ORXOF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Orexo AB Shiller PE Ratio Related Terms


Orexo AB Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Orexo AB's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orexo AB Shiller PE Ratio Chart

Orexo AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Orexo AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ORXOF vs ZTS: Shiller PE Ratio Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Orexo AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orexo AB Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexo AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Orexo AB's Shiller PE Ratio falls into.


ORXOF
27GF Score
Orexo AB ORXOF
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Orexo AB Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Orexo AB's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Orexo AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.307/134.6100*134.6100
=-0.307

Current CPI (Jun. 2026) = 134.6100.

Orexo AB Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 0.122 101.138 0.162
201612 0.104 102.022 0.137
201703 -0.112 102.022 -0.148
201706 0.010 102.752 0.013
201709 0.101 103.279 0.132
201712 0.092 103.793 0.119
201803 -0.091 103.962 -0.118
201806 0.165 104.875 0.212
201809 0.198 105.679 0.252
201812 0.163 105.912 0.207
201903 0.043 105.886 0.055
201906 0.160 106.742 0.202
201909 0.325 107.214 0.408
201912 0.117 107.766 0.146
202003 0.238 106.563 0.301
202006 -0.101 107.498 -0.126
202009 -0.277 107.635 -0.346
202012 -0.173 108.296 -0.215
202103 -0.108 108.360 -0.134
202106 -0.256 108.928 -0.316
202109 -0.175 110.338 -0.213
202112 -0.211 112.486 -0.253
202203 -0.072 114.825 -0.084
202206 -0.104 118.384 -0.118
202209 -0.071 122.296 -0.078
202212 -0.257 126.365 -0.274
202303 -0.178 127.042 -0.189
202306 -0.034 129.407 -0.035
202309 -0.088 130.224 -0.091
202312 -0.053 131.912 -0.054
202403 -0.025 132.205 -0.025
202406 -0.099 132.716 -0.100
202409 -0.118 132.304 -0.120
202412 -0.469 132.987 -0.475
202503 -0.045 132.825 -0.046
202506 -0.294 133.699 -0.296
202509 -0.092 133.480 -0.093
202512 -0.358 133.390 -0.361
202603 -0.409 133.560 -0.412
202606 -0.307 134.610 -0.307

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Orexo AB (ORXOF) Overvalued in 2026?

Based on GuruFocus' analysis, Orexo AB stock appears to be overvalued. The current stock price of $1.55 is trading 342.9% above its estimated GF Value™ of $0.35. GuruFocus considers Orexo AB to be Significantly Overvalued.

Key valuation signals for ORXOF:

  • Shiller PE Ratio:
  • GF Value™: $0.35 vs. price of $1.55 (342.9% above fair value)
  • GF Score™: 27/100 with 7 warning signs

No single metric tells the full story. See the ORXOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Orexo AB Business Description

Address Virdings alle 22, Uppsala, SWE, 75105
Orexo AB is a Swedish pharmaceutical company dedicated to advancing treatments for severe diseases and life-saving rescue medications to meet future healthcare needs, developing improved medications based on proprietary drug delivery technologies. At the core of its innovation is AmorphOX, which improves bioavailability and stability for both large and small molecules. It has developed four drugs from concept to approval, including Zubsolv, Abstral, Edluar, and Diabact UBT. The company's current development efforts focus on AmorphOX, with projects in preclinical and clinical phases across multiple therapeutic areas. It operates through US Commercial and HQ & Pipeline, which generate maximum revenue, and operates in the US, EU, and UK generating maximum revenue, and the Rest of the World.
27GF Score

Get the complete analysis for ORXOF

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.55
Price
$0.35
GF Value